Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center
This grant funds a center to coordinate research on the safest and most effective use of anti-obesity medications in children and teens, supporting clinical trials and data management across multiple sites.
Funder: National Institutes of Health
Due Dates: October 9, 2026
Funding Amounts: Estimated total program funding: $1,000,000; one award expected; duration not specified.
Summary: Supports a Research Coordinating Center to lead and harmonize efforts for a consortium testing anti-obesity medication strategies in children and adolescents.
Description
This opportunity invites applications for a Research Coordinating Center (RCC) to participate in a consortium focused on testing anti-obesity medication (AOM) treatment strategies for youth with obesity. The goal is to identify optimal use of AOMs that maximize benefits and minimize risks, supporting healthy growth, development, nutritional status, mental health, and quality of life in clinical care settings. The RCC will provide management, statistical leadership, research coordination, harmonization of data collection, database development, and foster collaborative research efforts. The consortium will work together on protocol development, use of common measures, centralized laboratory coordination, and standardized procedures for data and biospecimen collection.
